Cardiac denervation in patients with Parkinson disease

David S. Goldstein, MD, PhD
Clinical Neurocardiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD

Correspondence: David S. Goldstein, MD, PhD, Chief, Clinical Neurocardiology Section, CNP, DIR, NINDS, NIH, 10 Center Drive MSC-1620, Building 10, Room 6N252, Bethesda, MD 20892-1620; goldsteind@ninds.nih.gov

Dr. Goldstein reported that he has no financial relationships that pose a potential conflict of interest with this article.

This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Neurological Disorders and Stroke.

David S. Goldstein, MD, PhD
Clinical Neurocardiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD

Correspondence: David S. Goldstein, MD, PhD, Chief, Clinical Neurocardiology Section, CNP, DIR, NINDS, NIH, 10 Center Drive MSC-1620, Building 10, Room 6N252, Bethesda, MD 20892-1620; goldsteind@ninds.nih.gov

Dr. Goldstein reported that he has no financial relationships that pose a potential conflict of interest with this article.

This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Neurological Disorders and Stroke.

David S. Goldstein, MD, PhD
Clinical Neurocardiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD

Correspondence: David S. Goldstein, MD, PhD, Chief, Clinical Neurocardiology Section, CNP, DIR, NINDS, NIH, 10 Center Drive MSC-1620, Building 10, Room 6N252, Bethesda, MD 20892-1620; goldsteind@ninds.nih.gov

Dr. Goldstein reported that he has no financial relationships that pose a potential conflict of interest with this article.

This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Neurological Disorders and Stroke.